Occupational asthma |
|
|
Clinical Trial: Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma
This study is not yet open for patient recruitment.
|
Purpose
The purpose of this study is to identify the types of and frequency of use of complementary and alternative medicine (CAM) strategies among low-income Caucasian and African American adults with persistent asthma. The overall goal is to collect data that will increase understanding of health beliefs and behaviors in people with low-income backgrounds so that studies can be created that may help modify and improve patients' symptoms of asthma.
| Condition |
|---|
| Asthma |
MedlinePlus related topics: Asthma
Study Type: Observational
Study Design: Psychosocial, Cross-Sectional, Defined Population, Retrospective/Prospective Study
Official Title: The Role of Complementary and Alternative Medicine (CAM), Folk Care and Faith-based Approaches in the Home Management of Persistent Asthma in Low-Income African American and Caucasian Adults
Expected Total Enrollment: 50
Study start: November 2004
The rates of asthma-related deaths and disease are disproportionately high among African Americans compared to Caucasians. Surveys indicate that middle- and upper-income Caucasians use more CAM than African Americans, but the therapies utilized are different. This study will determine how well people with persistent asthma adhere to their treatment and whether the type and frequency of use of CAM affects treatment adherence.
Participants will begin this study by taking part in an interview about adherence to their current inhaled corticosteroids (ICS) regimen and their personal CAM use. After completing the interview, participant adherence to their ICS regimen will be monitored for 6 weeks. Depending on the type of ICS participants are taking, monitoring will be conducted either by participant self-reporting or electronic monitors that record the time and date of medication inhalation. Participant adherence will also be assessed at study completion.
Eligibility
Ages Eligible for Study: 21 Years - 50 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Physician-diagnosed asthma with episodes that last for long periods of time
- Medicaid recipients
- Self-identify as African American or Caucasian
- Daily use of inhaled corticosteroids
- Able to speak English
- Have mental capacity to understand and participate in the study
Exclusion Criteria:
- Prisoners
- History of smoking at least ten packs of cigarettes per year
- Currently smoke more than one and a half packs of cigarettes per week
Location Information
Maryland
Johns Hopkins Bayview Campus, Baltimore, Maryland, 21224, United States
Cynthia Rand, PhD 410-550-2516 crand@jhmi.edu
Maureen George, PhD, RN, AE-C, Sub-Investigator
Pennsylvania
Presbyterian Medical Center at the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States
Reynold Panettieri, MD 215-573-9860 rap@mail.med.upenn.edu
Maureen George, PhD, RN, AE-C, Principal Investigator
Maureen George, PhD, RN, AE-C, Principal Investigator, Johns Hopkins Medical Institute
More Information
Record last reviewed: November 2004
Last Updated: November 17, 2004
Record first received: October 18, 2004
ClinicalTrials.gov Identifier: NCT00094419
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Occupational asthma (MayoClinic)

Not Signed In -


